OR WAIT null SECS
© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.
October 18, 2021
The letter pointed to a single deficiency related to an open inspection issue at a third-party facility.
October 13, 2021
Data show the overall risk difference between the first and second doses of BNT162b2 was 1.76 per 100,000 persons.
In the primary endpoint, patients with severe HF had a 20% risk reduction compared to no significant treatment benefit in patients without severe HF.
October 12, 2021
Proposed new guidelines recommended against low-dose aspirin use for primary prevention of CVD in adults age 60 years or older, citing adverse effects.
October 10, 2021
A significantly increased risk of hospitalization from pneumonia was observed due to haemophilus influenzae.
October 09, 2021
Fever is present in both KD and MIS-C, but there is lower prevalence of the 5 KD defining clinical features in MIS-C.
Dr. Erickson discussed screening for children prone to sudden cardiac arrest and sudden cardiac death based on an updated AAP policy statement.
October 07, 2021
Differences in CV risk factors persisted between Black participants and White participants and may be due to social determinants of health.
October 04, 2021
Diabetes progression included greater likelihood of insulin treatment initiation, hyperglycemia, glycemic complications, and glucose-lowering prescriptions.
October 01, 2021
Data show SGLT2 inhibitor therapy, in comparison to GLP-1 RA therapy, was associated with slightly lower risk for myocardial infarction (MI) or stroke in patients with CVD.